Biosensors based on various spectroscopic techniques discriminate the target microRNA (miRNA) from non-target ones with single nucleotide polymorphisms (SNPs) according to the differences in signal intensities which can be caused by other factors besides SNPs. As a result, they are liable to produce false positive results. Herein, we report an attempt to develop a false-positive resistance, sensitive and reliable mass spectrometric platform for miRNA detection. In the proposed platform, the qualitative and quantitative information of the target miRNA was obtained through analyzing mass spectral responses of the multiply charged ions of the residual fragments of the probe DNA produced during exonuclease III assisted signal amplification reaction using an advanced data analysis method. The proposed platform could achieve sensitive and accurate quantitative results for the target miRNA (e.g., miRNA-141) in complex medium with a detection limit of about 1 pM, and unambiguously identify non-target miRNAs with SNPs based on the length distribution patterns of residual fragments of probe DNA. The findings obtained in this study might open an avenue for the design of new miRNA detection methods based on mass spectrometry in combination with various nuclease assisted signal amplification strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.talanta.2021.122414 | DOI Listing |
J Shoulder Elbow Surg
December 2024
Concordia Hospital, Rome, Italy.
Background: To analyze how patient history, glenoid bone loss (GBL), and the size of the residual glenoid bone fragment (GBF) influence the choice between arthroscopic Bankart repair and open Latarjet procedure in patients with anteroinferior glenohumeral instability and bony Bankart lesions.
Methods: Review of 290 patients with bony Bankart lesions treated for anterior glenohumeral instability was conducted and patients were categorized into three groups based on GBL and GBF: Group A (GBL < 10% and GBF <10%), Group B (GBL ≥ 10% and GBF <10%), and Group C (GBL ≥10%, GBF ≥10%). Number of preoperative dislocations, time from the first instability, Western Ontario Shoulder Index (WOSI) scores, Hill-Sachs lesion (HSL) location (central or peripheral), HSL track status, and Glenoid Track Instability Management Score (GTIMS) were analyzed.
Urolithiasis
December 2024
Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, Neue Stiftingtalstr. 6, 8010, Graz, Austria.
The primary objective of urolithiasis therapy is complete stone removal and highest stone-clearance rates possible to minimize recurrence. A novel approach that employs a magnetic suspension and a magnetic probe for the passive collection and removal of small residual fragments was developed. This study assessed the feasibility of this system in porcine models.
View Article and Find Full Text PDFWorld J Urol
December 2024
Progressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.
Purpose: Use of suction in flexible ureteroscopy is increasing lately. The introduction of flexible and navigable suction access sheath (FANS) has shown improved stone free rate (SFR). However, its efficacy in lower pole stone (LPS) in terms of SFR and complications is yet to be studied.
View Article and Find Full Text PDFCancer Med
December 2024
Research & Development, SeekIn Inc., San Diego, California, USA.
Background And Purpose: Liver cancer has a high recurrence rate of 50%~70% for early-stage patients. Minimal residual disease (MRD) is strongly linked to liver cancer early recurrence. Identifying MRD through reliable prognostic biomarkers, such as circulating tumor DNA (ctDNA), could significantly benefit these patients by enabling timely intervention and improved outcomes.
View Article and Find Full Text PDFEur J Immunol
December 2024
Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, CNRS, Sorbonne Université, Université Paris Cité, Paris, France.
Imlifidase (IdeS) is a bacterial protease that hydrolyzes human IgG in their hinge region, decreasing their half-life and abrogating their Fc-mediated properties. It is now successfully used in therapy to prevent graft rejection during kidney transplants and is being clinically evaluated in several IgG-mediated autoimmune diseases. IdeS short half-life however limits its clinical use, particularly in the case of chronic diseases that would request repeated administrations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!